Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind multi-dose placebo-controlled study of fesoterodine in stress urinary incontinence
2008-005350-21Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stress urinary incontinence (SUI) comparing Fesoterodine with Placebo (2 arms). Primary endpoint: Change in urethral tone. Started Jan 2009; status: completed.
02
Drugs
fesoterodine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on 2008-005350-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005350-21.